Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Cefzil Suspension 125mg*


Contraindicated

May be acceptable
Use with caution
Cefzil Suspension 125mg* :
Type Medicine Non Marketed
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory GSK
Responsible Party Bristol-Myers Barceloneta Inc
Origin U.S.A.
Manufacturer Bristol-Myers Barceloneta Inc
Origin U.S.A.
ATC J01DC10

Your comment will appear shortly after approval

Cefzil Suspension 125mg* :

Revision Date : 01/12/2010


Effect Frequency
Abdominal pain Common
ALT increased Common
AST increased Common
Blood bilirubin increased Uncommon
Blood urea nitrogen (BUN) increased Uncommon
Colitis Rare
Confusion Rare
Diaper rash Common
Diarrhoea (Diarrhea) Common
Dizziness Common
Eosinophil count decreased Uncommon
Headache Rare
Hyperactivity (Increased activity) Rare
Insomnia Rare
Jaundice cholestatic (Cholestatic icterus) Rare
Nausea Common
Nervousness Rare
Phosphatase alkaline increased Uncommon
Prothrombin time prolonged Rare
Pruritus genital Common
Pseudomembranous colitis Rare
Serum creatinine increased Uncommon
Serum sickness Rare
Skin rash Uncommon
Somnolence Rare
Superinfection Common
Urticaria Uncommon
Vaginismus Common
Vomiting Common
WBC abnormal NOS Uncommon

Different Units By MoH Code

Revision Date : 01/12/2010

Cefzil Suspension 125mg*  MoH 926 :
Form Powder for oral suspension
Packaging Bottle
Package Size 50ml
Strength 125mg/5ml
NSSF ✘
Quarantine ✘
Reg. Number 208326/97
Submission date 01/01/1997
Registration Year 1997
Archived Date 2014


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info